ReviewFrontiers in oncology2022
Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer.
Chenyi Luo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
80 papers cite itlatest 60 shown
this paperpooled itcites it
ReviewFrontiers in oncology2022
Chenyi Luo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.